FBLG – fibrobiologics, inc. (US:NASDAQ)

News

FibroBiologics Compliant with All Nasdaq Listing Requirements
FibroBiologics (FBLG) had its "buy" rating reaffirmed by HC Wainwright.
FibroBiologics Presents Novel Thymus Organoid Platform to Combat Age-Related Immune Decline at Keystone Symposia on Aging and Immunity
FibroBiologics (FBLG) was upgraded by Wall Street Zen to "sell".
FibroBiologics Announces Closing of $3 Million Public Offering
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com